StockData
SeaStar Medical Holding Corp logo

SeaStar Medical Holding Corp (ICU) shareholders

ICUNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICUCW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3071% below fair value
$0.78−0.07 (-8.49%)

Close on Nov 17, 2026Market cap $3.44MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0M
Shares held, 13F filers
Institutional holders
18
3 new, 1 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $17.25K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Mitchell P. Kopin
Joint filing with Daniel B. Asher (9.99%), Intracoastal Capital LLC (9.99%)
3,098,1759.99%13G (passive) amendmentSep 30, 2025
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
1,019,9589.99%13G (passive)Mar 31, 2025
Intracoastal Capital LLC
Joint filing with Mitchell P. Kopin (9.99%), Daniel B. Asher (9.99%)
489,1059.99%13G (passive) amendmentSep 30, 2026
Daniel B. Asher
Joint filing with Mitchell P. Kopin (9.99%), Intracoastal Capital LLC (9.99%)
443,2539.99%13G (passive) amendmentMar 31, 2026
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Joint filing with Ayrton Capital LLC (6.52%), Waqas Khatri (6.52%)
278,4366.52%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ICUValueChange% of portfolio
Geode Capital Management, LLC49,593–$182.01K−6,0490.00%
Vanguard Capital Management LLC33,091–$121.44K+4,3000.00%
UBS Group AG31,398–$115.23K+30,6050.00%
Vanguard Fiduciary Trust Co13,692–$50.25K–0.00%
Jane Street Group, LLC12,634–$46.37K−15,3260.00%
Northern Trust Corp10,402–$38.18KNew0.00%
PNC Financial Services Group, Inc.4,943–$18.14K+3,1950.00%
Tower Research Capital LLC (TRC)1,356–$4.98K−390.00%
BlackRock, Inc.913–$3.35K–0.00%
Osaic Holdings, Inc.195–$714−350.00%
NewEdge Advisors, LLC176–$647–0.00%
Vanguard Global Advisers, LLC165–$606–0.00%
TD Waterhouse Canada Inc.22–$106–0.00%
SBI Securities Co., Ltd.14–$51–0.00%
SOA Wealth Advisors, LLC.6–$22–0.00%
Barclays PLC4–$15New0.00%
HighMark Wealth Management LLC2–$7–0.00%
Caitong International Asset Management Co., Ltd2–$7New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 2026180M3 / 34 / 10M0M
Q1 2026170M15 / 01 / 00M0M
Q4 202520M2 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

6 funds held ICU in Q2 2026, 48% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ICUValue% of fundAs of
Vanguard Extended Market Index Fund33,091–$121.44K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund21,929–$81.36K0.00%May 31, 2026
Fidelity Total Market Index Fund8,656–$32.11K0.00%May 31, 2026
Fidelity Series Total Market Index Fund5,814–$21.57K0.00%May 31, 2026
Dimensional U.S. Core Equity 2 ETF2,835–$8.87K0.00%Jul 31, 2026
Fidelity Nasdaq Composite Index Fund447–$1.66K0.00%May 31, 2026
Blackstone Alternative Multi-Strategy Fund-700–-$2.57K-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Michael MessingerChief Financial Officer5,000Nov 17, 2026
Kevin ChungChief Medical Officer35,821Nov 17, 2026
Eric SchlorffChief Executive Officer50,140Jul 2, 2026
Bradford K. TownePrincipal Accounting Officer9,050Feb 10, 2026
David A. GreenChief Financial Officer10,323Apr 3, 2025
Heel Kenneth VanDirector11,940Jul 2, 2026
Bernadette N. VincentDirector8,200Jul 2, 2026
Jennifer A. BairdDirector10,620Jul 2, 2026
John NeumanDirector16,200Jul 2, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Michael Messinger
Chief Financial Officer
Nov 16, 2026Buy+2,500$0.85$2.12K5,000
Kevin Chung
Chief Medical Officer
Nov 16, 2026Buy+7,800$0.84$6.59K35,821
Michael Messinger
Chief Financial Officer
Aug 18, 2026Buy+750$3.27$2.45K2,500
John Neuman
Director
Jul 1, 2026Award+4,000––16,200
Jennifer A. Baird
Director
Jul 1, 2026Award+4,000––10,620
Eric Schlorff
Chief Executive Officer
Jul 1, 2026Award+10,288––50,140
Heel Kenneth Van
Director
Jul 1, 2026Award+4,000––11,940
Bernadette N. Vincent
Director
Jul 1, 2026Award+4,000––8,200
Kevin Chung
Chief Medical Officer
Jul 1, 2026Award+7,202––28,021
Jennifer A. Baird
Director
Feb 6, 2026Award+3,000––6,620
Eric Schlorff
Chief Executive Officer
Feb 6, 2026Award+30,000––39,852
Bradford K. Towne
Principal Accounting Officer
Feb 6, 2026Award+7,500––9,050
Kevin Chung
Chief Medical Officer
Feb 6, 2026Award+15,000––20,819
John Neuman
Director
Feb 6, 2026Award+3,000––12,200
Bernadette N. Vincent
Director
Feb 6, 2026Award+3,000––4,200
Heel Kenneth Van
Director
Feb 6, 2026Award+3,000––7,940
Jennifer A. Baird
Director
Dec 19, 2025Buy+4,200$0.24$1.01K36,200
Michael Messinger
Chief Financial Officer
Dec 9, 2025Buy+14,500$0.35$5.08K17,500
Heel Kenneth Van
Director
Aug 27, 2025Buy+10,000$0.86$8.60K49,400
Heel Kenneth Van
Director
Aug 26, 2025Buy+25,000$0.89$22.25K39,400
Kevin Chung
Chief Medical Officer
Aug 22, 2025Buy+10,000$0.80$8.00K58,184
Bernadette N. Vincent
Director
Jul 10, 2025Award+4,000––12,000
Heel Kenneth Van
Director
Jul 10, 2025Award+4,000––14,400
John Neuman
Director
Jul 10, 2025Award+4,000––92,000
Jennifer A. Baird
Director
Jul 10, 2025Award+4,000––32,000
Eric Schlorff
Chief Executive Officer, Director
Jul 1, 2025Option exercise+21,667––98,517
Kevin Chung
Chief Medical Officer
Jul 1, 2025Option exercise+5,000––48,184
Jennifer A. Baird
Director
Jun 30, 2025Buy+10,000$0.42$4.20K28,000
John Neuman
Director
Jun 24, 2025Buy+40,000$0.36$14.40K80,000
Bernadette N. Vincent
Director
Jun 4, 2025Option exercise+2,667––8,000
Heel Kenneth Van
Director
Jun 4, 2025Option exercise+4,000––10,400
John Neuman
Director
Jun 4, 2025Option exercise+2,667––88,000
Jennifer A. Baird
Director
Jun 4, 2025Option exercise+2,667––18,000
Jennifer A. Baird
Director
May 20, 2025Buy+10,000$1.28$12.80K10,000
Kevin Chung
Chief Medical Officer
May 20, 2025Buy+4,500$1.25$5.63K18,185
John Neuman
Director
Dec 11, 2024Buy+10,000$2.04$20.40K40,000
Kevin Chung
Chief Medical Officer
Nov 18, 2024Buy+4,250$1.99$8.46K13,685
Kevin Chung
Chief Medical Officer
Sep 30, 2024Buy+1,000$4.26$4.26K9,435
David A. Green
Chief Financial Officer
Aug 30, 2024Award+8,100––10,323
John Neuman
Director
Aug 15, 2024Buy+10,000$5.24$52.40K30,000
John Neuman
Director
Jun 17, 2024Buy+10,000$4.35$43.50K20,000
John Neuman
Director
Jun 14, 2024Buy+10,000$3.69$36.90K10,000
David A. Green
Chief Financial Officer
Apr 18, 2024Award+2,223––2,223
Allan Collins
Director
Apr 12, 2024Award+37,943––54,343
Bruce M. Rodgers
Director
Apr 12, 2024Award+36,537––44,515
Heel Kenneth Van
Director
Apr 12, 2024Award+43,564––159,964
Andres Lobo
Director
Apr 12, 2024Award+32,322––40,300
Rick Barnett
Director
Apr 12, 2024Award+70,264––86,664
David A. Green
Chief Financial Officer
Apr 12, 2024Award+752,500––752,500
Richard D. Russell
Director
Apr 12, 2024Award+32,322––60,300
Kevin Chung
Chief Medical Officer
Nov 29, 2023Award+63,422––210,860
Eric Schlorff
Chief Executive Officer, Director
Nov 29, 2023Award+60,248––837,823
Caryl Baron
Interim CFO
Nov 29, 2023Award+20,293––139,872
Heel Kenneth Van
Director
Nov 22, 2023Buy+100,000$0.40$40.00K116,400
Caryl Baron
Interim CFO
Sep 22, 2023Other+15,070––119,579
Caryl Baron
Interim CFO
Sep 15, 2023Award+4,110––104,506
Eric Schlorff
Chief Executive Officer, Director
Sep 15, 2023Award+41,109––779,862
Kevin Chung
Chief Medical Officer
Sep 15, 2023Award+34,257––154,490
Kevin Chung
Chief Medical Officer
Aug 31, 2023Award+28,125––113,181
Eric Schlorff
Chief Executive Officer, Director
Aug 31, 2023Award+33,750––736,466

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.3
At 0M shares a day
Change since last report
-5.7%
From 0M shares
Short volume, 20 days
45.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of SeaStar Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 151,970 shares on Oct 8, 2026 over the last 90 days.

See a number that looks wrong?